$INFQ

MAVERICK CAPITAL LTD (AINSLIE LEE S III) sold $2.6M of INFQ (indirect holdings)

MAVERICK CAPITAL LTD sold 198,229 indirectly-held shares of Infleqtion, Inc. (INFQ) at an average of $12.95 ($12.62–$13.02, $2.57M total) across 2 trades over 2026-08-19 to 2026-08-21. Filed jointly with MAVERICK CAPITAL MANAGEMENT LLC (Director) and AINSLIE LEE S III (Director).

Original reporting
SEC EDGAR · MAVERICK CAPITAL LTD, MAVERICK CAPITAL MANAGEMENT LLC, AINSLIE LEE S III
Published Aug 21, 2026, 11:42 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 22, 2026, 12:06 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$INFQ
Bearish
medium confidence
Mentioned
$INFQ
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$INFQBearishLow
01

Why it matters

The disclosed insider sale provides fresh data on insider sentiment, which can influence short‑term trading decisions.

02

Market read

First‑report insider sale; modest size but may affect price perception.

03

What to watch

No 10b5‑1 plan; sale may be opportunistic given recent price range.

Relevance 6/10Novelty 7/10Timing: filed today

Background

Infleqtion Inc. (NASDAQ:INFQ) is a micro‑cap focused on quantum‑enabled photonic chips.

Company-level read

Ticker impact

$INFQBearishMedium confidence
Context

Form 4 disclosed a director sold ~2.6M USD of INFQ shares on 2026-08-19/21.

Expected impact

Potential short-term downward pressure.

Evidence & confidence

Director sale size is modest but notable for a micro‑cap; market may react negatively.

Market effects

Minimal impact on semiconductor equipment sector.

Limited to US micro‑cap investors.

Low

Counterpoint

Sale could be routine portfolio rebalancing, not a bearish signal.

Key entities

  • Infleqtion, Inc.

    Issuer of the shares sold.

  • Maverick Capital Ltd.

    Director and reporting entity.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$INFQHigh

What's Going On With Infleqtion Stock Thursday?

Infleqtion Inc. (INFQ) rose 4.73% to $14.17 on Thursday. NASA awarded the company a $20 million contract for a space-based quantum sensor, doubling its investment to $40 million. The stock is 15% above its 20-day moving average and has a consensus Buy rating with an average price target of $21.33.

$INFQMed

Japan Enters Neutral-Atom Race With Shunkai, Its First Full-Stack Quantum Computer

Japan's Institute for Molecular Science launched Shunkai, its first full-stack neutral-atom quantum computer, developed with Hitachi and Infleqtion (NYSE: INFQ). Shunkai operates at room temperature, offering advantages over superconducting qubits, and reflects Japan's strategic bet on neutral-atom technology. Infleqtion's QPU is central to the system, with Hitachi providing the software stack. INFQ shares fell 7.12% on the announcement day, attributed to 'sell the news' dynamics.

$INFQMedAI 8/10

Infleqtion updates Q2 revenue to $13.5M, raises FY26 guidance

Infleqtion (NYSE: INFQ) updated Q2 2026 revenue to $13.5M from $12.6M due to revised timing of two government contracts. It raised FY26 revenue guidance to about $45.1M from $43M. GAAP operating loss was $29.9M. The company also cited LOIs and customer deployments, including an Eaton/ARFL grid-resilience research subcontract.

$INFQMed

Infleqtion (NASDAQ: INFQ) flags revenue errors across 2024-26

Infleqtion (NASDAQ: INFQ) said it is delaying its Q2 2026 Form 10-Q for the quarter ended June 30, 2026 to complete a review of revenue recognition and GAAP accounting for expected project losses. The review found errors requiring adjustments to 2024-2025 and early 2026 periods, mainly shifting revenue into 2026. As adjusted, Q2 2026 revenue rises to 13.538m from 12.633m and net loss narrows to 24.695m from 25.473m; it expects to file within the Rule 12b-25 extension.